Kures

0 followers


Kures is a pre-clinical-stage biopharmaceutical startup that develops opioid-based treatments for depressive disorder.The biopharmaceutical company is also interested in addressing other challenging indications in the psychiatry and physical pain arena using its portfolio of novel small molecules. I... Read more

Industries

+2

Headquarters

Employees

Links

Org chart

Chad Beyer
Ph.d., CEO

Chad Beyer

Collapse
Glenn Short
Translational Lead
Cara Baugh
Member Board Of Directors